Efficacy News and Research

RSS

Saving sight of millions by making eye injections safe and comfortable

Two eye surgeons have written a first-of-its-kind book to save the sight of millions of patients around the world by making eye injections safe and comfortable.

7 Aug 2018

FDA issues scientific recommendations to encourage development of novel drugs for treatment of OUD

The U.S. Food and Drug Administration today issued new scientific recommendations aimed at encouraging more widespread innovation and development of novel medication-assisted treatment drugs for the treatment of opioid use disorder.

7 Aug 2018

Regenacy Pharmaceuticals partners with CMTA to advance ricolinostat for treating hereditary neuropathy

Regenacy Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company developing breakthrough treatments for diabetic and other peripheral neuropathies, today announced a collaboration with the Charcot-Marie-Tooth Association, a registered non-profit organization serving the hereditary neuropathy patient community, to validate the role of HDAC6 in multiple forms of Charcot-Marie-Tooth disease and evaluate the efficacy of ricolinostat, a selective HDAC6 inhibitor, in animal models.

2 Aug 2018

Otsuka’s JINARC approved for treatment of patients with CKD stage 4 ADPKD

Otsuka Pharmaceutical Europe Ltd. today announced that the European Commission has approved an extension of indication for JINARC to include adult patients with CKD stage 4 Autosomal Dominant Polycystic Kidney Disease

2 Aug 2018

Scientists develop simple, innovative method to convert white fat to brown fat

Brown fat tissue in the body can burn enormous amounts of energy to generate heat, and studies in humans and animals have suggested that increasing the amount of healthy brown fat might help weight management and reduce symptoms of diabetes.

2 Aug 2018

RBC-hitchhiking method increases concentration of drugs ferried to selected organs

A new drug-delivery technology which uses red blood cells to shuttle nano-scale drug carriers, called RBC-hitchhiking, has been found in animal models to dramatically increase the concentration of drugs ferried precisely to selected organs, according to a study published in Nature Communications this month by researchers from the Perelman School of Medicine at the University of Pennsylvania.

2 Aug 2018

New drug cocktails make targeted cancer therapies more efficient with less side effects

Mount Sinai researchers have discovered that certain drug cocktails help targeted therapies attack cancer more efficiently while lessening common side effects, according to a study published today in Cancer Research.

1 Aug 2018

Catalytic nanoparticles can effectively prevent tooth decay

Combine a diet high in sugar with poor oral hygiene habits and dental cavities, or caries, will likely result.

1 Aug 2018

Researchers engineer three cell lines to produce nonproprietary versions of NISTmAb

When the National Institute of Standards and Technology issued the world's first standardized monoclonal antibody in July 2016, the exhaustively analyzed protein known as NISTmAb was intended as a valuable tool for biopharmaceutical companies.

1 Aug 2018

New discovery may lead to targeted treatment for copper metabolism disorders

Individuals with defects in copper metabolism may soon have more targeted treatment options thanks to a discovery by a research team led by Dr. Vishal Gohil of Texas A&M AgriLife Research in College Station.

31 Jul 2018

Glaucoma Research Foundation-funded research makes breakthrough in treatment of glaucoma

Glaucoma Research Foundation, a national non-profit organization dedicated to finding a cure for glaucoma, today announced a team of neuroscience researchers, led by Adriana Di Polo, PhD, at University of Montreal, have made a major breakthrough in the treatment of glaucoma.

31 Jul 2018

European Commission approves Pfizer’s first oncology biosimilar

Pfizer Inc. today announced the European Commission has approved TRAZIMERA, a biosimilar to Herceptin (trastuzumab), for the treatment of human epidermal growth factor overexpressing breast cancer and HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.

31 Jul 2018

New real-time strategy to combat future outbreaks of foot-and-mouth disease

Future outbreaks of foot-and-mouth disease can be combatted quickly and efficiently from early on - when authorities have minimal information - thanks to a new real-time strategy, developed by researchers at the University of Warwick.

31 Jul 2018

FDA approves first therapy for patients with rare tumors of the adrenal gland

The U.S. Food and Drug Administration today approved Azedra (iobenguane I 131) injection for intravenous use for the treatment of adults and adolescents age 12 and older with rare tumors of the adrenal gland (pheochromocytoma or paraganglioma) that cannot be surgically removed (unresectable), have spread beyond the original tumor site and require systemic anticancer therapy.

31 Jul 2018

New study provides insight into how stimulant treatments for ADHD work

Stimulant medications are an effective treatment for Attention-Deficit/Hyperactivity Disorder. In the classroom, parents and teachers say that medications like methylphenidate can reduce symptoms and improve behavior.

28 Jul 2018

$Researchers use magnetic surgical cement for spinal fractures and targeted drug delivery$

Researchers use magnetic surgical cement for spinal fractures and targeted drug delivery

Patients with spinal fractures caused by tumors or osteoporosis usually undergo a procedure called kyphoplasty, where the fracture is filled with surgical cement.

28 Jul 2018

Philips and Oxford University Hospitals NHS Foundation Trust join hands to set up digital pathology network

Royal Philips, a global leader in health technology, and Oxford University Hospitals (OUH) NHS Foundation Trust, today announced plans to create a digital pathology network to help drive faster and more efficient diagnoses for patients.

From Philips Healthcare 27 Jul 2018

PEACHI project develops vaccine strategies targeting both HIV and hepatitis C virus

An estimated 2.3 million people globally are infected with both human immunodeficiency virus type 1 and hepatitis C virus.

27 Jul 2018

Therapy with L-Glutamine reduces pain in patients with sickle cell disease

UCSF Benioff Children's Hospital Oakland clinical researchers, in conjunction with other sickle cell centers and scientists at Emmaus Life Sciences, Inc., have demonstrated that therapy with L-Glutamine reduced the frequency of pain episodes in both pediatric and adult patients with sickle cell disease.

27 Jul 2018

Researchers develop nano-carriers to specifically target senescent cells

Senescent cells are damaged cells that do not perform their normal roles anymore but that are not dead -hence they are commonly known as zombi cells.

27 Jul 2018

Efficacy News and Research

Saving sight of millions by making eye injections safe and comfortable

FDA issues scientific recommendations to encourage development of novel drugs for treatment of OUD

Regenacy Pharmaceuticals partners with CMTA to advance ricolinostat for treating hereditary neuropathy

Otsuka’s JINARC approved for treatment of patients with CKD stage 4 ADPKD

Scientists develop simple, innovative method to convert white fat to brown fat

RBC-hitchhiking method increases concentration of drugs ferried to selected organs

New drug cocktails make targeted cancer therapies more efficient with less side effects

Catalytic nanoparticles can effectively prevent tooth decay

Researchers engineer three cell lines to produce nonproprietary versions of NISTmAb

New discovery may lead to targeted treatment for copper metabolism disorders

Glaucoma Research Foundation-funded research makes breakthrough in treatment of glaucoma

European Commission approves Pfizer’s first oncology biosimilar

New real-time strategy to combat future outbreaks of foot-and-mouth disease

FDA approves first therapy for patients with rare tumors of the adrenal gland

New study provides insight into how stimulant treatments for ADHD work

Researchers use magnetic surgical cement for spinal fractures and targeted drug delivery

Philips and Oxford University Hospitals NHS Foundation Trust join hands to set up digital pathology network

PEACHI project develops vaccine strategies targeting both HIV and hepatitis C virus

Therapy with L-Glutamine reduces pain in patients with sickle cell disease

Researchers develop nano-carriers to specifically target senescent cells

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News